✦ LIBER ✦

Crizotinib: a guide to its use in previously treated advanced anaplastic lymphoma kinase-positive non-small cell lung cancer in the EU

✍ Scribed by Hines, Mary; Lyseng-Williamson, Katherine A.; Curran, Monique P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crizotinib: A Review of Its Use in the T

✍ Frampton, James E. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 517 KB

369 Timing of responses to crizotinib (P

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Favorable response to crizotinib in thre

✍ Takashi Kijima; Kengo Takeuchi; Satoshi Tetsumoto; Kazuki Shimada; Ryo Takahashi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

PCN73 Economic Analysis of the Use of Cr

✍ J.G. Gay-Molina; R. Sánchez-Kobashi; E. Muciño-Ortega; C.I. Gutiérrez-Colín; R.M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Prognostic factors in previously treated

✍ Wataya, Hiroshi; Okamoto, Tatsuro; Maruyama, Riichiroh; Seto, Takashi; Yamazaki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A Phase II Trial of Saracatinib, an Inhi

✍ Laurie, Scott A.; Goss, Glenwood D.; Shepherd, Frances A.; Reaume, M. Neil; Nich 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 205 KB